<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2026 [PPXK5GW761L0VCG2VY7A]. www.edgarsuite.com -->
<schema attributeFormDefault='unqualified' elementFormDefault='qualified' targetNamespace='http://biosciencehealthinnovation.com/20260630' xmlns='http://www.w3.org/2001/XMLSchema' xmlns:xbrli='http://www.xbrl.org/2003/instance' xmlns:fil='http://biosciencehealthinnovation.com/20260630' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns:xbrldt='http://xbrl.org/2005/xbrldt' xmlns:dei='http://xbrl.sec.gov/dei/2026' xmlns:dtr-types='http://www.xbrl.org/dtr/type/2020-01-21' xmlns:srt='http://fasb.org/srt/2026' xmlns:us-gaap='http://fasb.org/us-gaap/2026'>
	<annotation>
		<appinfo>
			<link:linkbaseRef xlink:type="simple" xlink:href="bhic-20260630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="bhic-20260630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="bhic-20260630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="bhic-20260630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote6DigitalAssetsCryptoAssetActivityTables" id="idr_DisclosureNote6DigitalAssetsCryptoAssetActivityTables">
				<link:definition>000330 - Disclosure - Note 6 - Digital Assets: Crypto Asset, Activity (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote5EquityDetails" id="idr_DisclosureNote5EquityDetails">
				<link:definition>000460 - Disclosure - Note 5 - Equity (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesSegmentReportingPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesSegmentReportingPolicies">
				<link:definition>000160 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Segment Reporting (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_StatementCondensedConsolidatedStatementsOfStockholdersEquityDeficit" id="idr_StatementCondensedConsolidatedStatementsOfStockholdersEquityDeficit">
				<link:definition>000050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY (DEFICIT)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_StatementCondensedConsolidatedStatementsOfCashFlows" id="idr_StatementCondensedConsolidatedStatementsOfCashFlows">
				<link:definition>000060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesIncomeTaxesPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesIncomeTaxesPolicies">
				<link:definition>000200 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Income Taxes (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote4RelatedPartyTransactions" id="idr_DisclosureNote4RelatedPartyTransactions">
				<link:definition>000100 - Disclosure - Note 4 - Related Party Transactions</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote5Equity" id="idr_DisclosureNote5Equity">
				<link:definition>000110 - Disclosure - Note 5 - Equity</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote2Liquidity" id="idr_DisclosureNote2Liquidity">
				<link:definition>000080 - Disclosure - Note 2 - Liquidity</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_StatementCondensedConsolidatedStatementsOfOperations" id="idr_StatementCondensedConsolidatedStatementsOfOperations">
				<link:definition>000040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesLesseeLeasesPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesLesseeLeasesPolicies">
				<link:definition>000270 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Lessee, Leases (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesInventoryPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesInventoryPolicies">
				<link:definition>000190 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Inventory (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote7SubsequentEvents" id="idr_DisclosureNote7SubsequentEvents">
				<link:definition>000130 - Disclosure - Note 7 - Subsequent Events</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails">
				<link:definition>000350 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsPolicies">
				<link:definition>000170 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote6DigitalAssetsCryptoAssetActivityDetails" id="idr_DisclosureNote6DigitalAssetsCryptoAssetActivityDetails">
				<link:definition>000480 - Disclosure - Note 6 - Digital Assets: Crypto Asset, Activity (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesImpairmentOfLongLivedAssetsPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesImpairmentOfLongLivedAssetsPolicies">
				<link:definition>000250 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Impairment of Long-lived Assets (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesResearchAndDevelopmentDetails" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesResearchAndDevelopmentDetails">
				<link:definition>000400 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Research and Development (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote6DigitalAssetsCryptoAssetHoldingDetails" id="idr_DisclosureNote6DigitalAssetsCryptoAssetHoldingDetails">
				<link:definition>000470 - Disclosure - Note 6 - Digital Assets: Crypto Asset, Holding (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesAccountsReceivableAndAllowanceForDoubtfulAccountsDetails" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesAccountsReceivableAndAllowanceForDoubtfulAccountsDetails">
				<link:definition>000360 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Accounts Receivable and Allowance for Doubtful Accounts (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesFairValueOfFinancialInstrumentsFairValueAssetsMeasuredOnRecurringBasisTables" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesFairValueOfFinancialInstrumentsFairValueAssetsMeasuredOnRecurringBasisTables">
				<link:definition>000310 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments: Fair Value, Assets Measured on Recurring Basis (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesAccountsReceivableAndAllowanceForDoubtfulAccountsPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesAccountsReceivableAndAllowanceForDoubtfulAccountsPolicies">
				<link:definition>000180 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Accounts Receivable and Allowance for Doubtful Accounts (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies">
				<link:definition>000140 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Basis of Presentation (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesLesseeLeasesDetails" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesLesseeLeasesDetails">
				<link:definition>000420 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Lessee, Leases (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesResearchAndDevelopmentPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesResearchAndDevelopmentPolicies">
				<link:definition>000230 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Research and Development (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesFairValueOfFinancialInstrumentsPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesFairValueOfFinancialInstrumentsPolicies">
				<link:definition>000300 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote6DigitalAssetsCryptoAssetHoldingTables" id="idr_DisclosureNote6DigitalAssetsCryptoAssetHoldingTables">
				<link:definition>000320 - Disclosure - Note 6 - Digital Assets: Crypto Asset, Holding (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesAdvertisingCostsPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesAdvertisingCostsPolicies">
				<link:definition>000220 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Advertising Costs (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicies">
				<link:definition>000210 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Revenue Recognition (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesIntangibleAssetsDetails" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesIntangibleAssetsDetails">
				<link:definition>000410 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Intangible Assets (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DocumentDocumentAndEntityInformation" id="idr_DocumentDocumentAndEntityInformation">
				<link:definition>000010 - Document - Document and Entity Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote6DigitalAssets" id="idr_DisclosureNote6DigitalAssets">
				<link:definition>000120 - Disclosure - Note 6 - Digital Assets</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails">
				<link:definition>000430 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Net Income (Loss) per Common Share (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesUseOfEstimatesPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesUseOfEstimatesPolicies">
				<link:definition>000150 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Use of Estimates (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesFairValueOfFinancialInstrumentsFairValueAssetsMeasuredOnRecurringBasisDetails" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesFairValueOfFinancialInstrumentsFairValueAssetsMeasuredOnRecurringBasisDetails">
				<link:definition>000440 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments: Fair Value, Assets Measured on Recurring Basis (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_StatementCondensedConsolidatedBalanceSheets" id="idr_StatementCondensedConsolidatedBalanceSheets">
				<link:definition>000020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails">
				<link:definition>000380 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Revenue Recognition (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote2LiquidityDetails" id="idr_DisclosureNote2LiquidityDetails">
				<link:definition>000340 - Disclosure - Note 2 - Liquidity (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesInventoryDetails" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesInventoryDetails">
				<link:definition>000370 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Inventory (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesRecentAccountingPronouncementsPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesRecentAccountingPronouncementsPolicies">
				<link:definition>000290 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Recent Accounting Pronouncements (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote1NatureOfOrganization" id="idr_DisclosureNote1NatureOfOrganization">
				<link:definition>000070 - Disclosure - Note 1 - Nature of Organization</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_StatementCondensedConsolidatedBalanceSheetsParenthetical" id="idr_StatementCondensedConsolidatedBalanceSheetsParenthetical">
				<link:definition>000030 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS - Parenthetical</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesDigitalAssetsHeldForOperationalPurposesPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesDigitalAssetsHeldForOperationalPurposesPolicies">
				<link:definition>000260 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Digital Assets Held for Operational Purposes (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesAdvertisingCostsDetails" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesAdvertisingCostsDetails">
				<link:definition>000390 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Advertising Costs (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonSharePolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonSharePolicies">
				<link:definition>000280 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Net Income (Loss) per Common Share (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies">
				<link:definition>000240 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Intangible Assets (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote4RelatedPartyTransactionsDetails" id="idr_DisclosureNote4RelatedPartyTransactionsDetails">
				<link:definition>000450 - Disclosure - Note 4 - Related Party Transactions (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://biosciencehealthinnovation.com/20260630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPolicies" id="idr_DisclosureNote3SummaryOfSignificantAccountingPolicies">
				<link:definition>000090 - Disclosure - Note 3 - Summary of Significant Accounting Policies</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
		</appinfo>
	</annotation>
	<import schemaLocation='https://www.xbrl.org/dtr/type/2020-01-21/types.xsd' namespace='http://www.xbrl.org/dtr/type/2020-01-21'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='https://xbrl.sec.gov/dei/2026/dei-2026.xsd' namespace='http://xbrl.sec.gov/dei/2026'/>
	<import schemaLocation='https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd' namespace='http://fasb.org/srt/2026'/>
	<import schemaLocation='https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd' namespace='http://fasb.org/us-gaap/2026'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_LeaseCostNetOfRepayments' name='LeaseCostNetOfRepayments'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_OperatingDigitalAssets' name='OperatingDigitalAssets'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_ConversionOfRelatedPartyAdvancesToRelatedPartyNotePayable' name='ConversionOfRelatedPartyAdvancesToRelatedPartyNotePayable'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_PurchaseOfInventoryWithDigitalAssets' name='PurchaseOfInventoryWithDigitalAssets'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_OperatingExpensesPaidWithDigitalAssets' name='OperatingExpensesPaidWithDigitalAssets'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_CommonStockIssuedForCashValue' name='CommonStockIssuedForCashValue'/>
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CommonStockIssuedForCashShares' name='CommonStockIssuedForCashShares'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_RepaymentOfRelatedPartyNotePayable' name='RepaymentOfRelatedPartyNotePayable'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_NetWorkingCapital' name='NetWorkingCapital'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_BalanceInExcessOfFdicLimit' name='BalanceInExcessOfFdicLimit'/>
	<element nillable='true' type='dtr-types:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_DigitalAssetsHeldForOperationalPurposesTextBlock' name='DigitalAssetsHeldForOperationalPurposesTextBlock'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_LeasePrepayment' name='LeasePrepayment'/>
	<element abstract='true' nillable='true' type='dtr-types:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedParty1Member' name='RelatedParty1Member'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_PromissoryNote' name='PromissoryNote'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_PaymentsForServices' name='PaymentsForServices'/>
	<element abstract='true' nillable='true' type='dtr-types:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_UsdtMember' name='UsdtMember'/>
</schema>
